Every long-term investor eventually meets the same quiet problem. A company you bought years ago, at a price that felt entirely reasonable at the time, has simply done what you hoped it would do — grown. And grown. Until, almost without anyone deciding it should, it has become the largest thing in your portfolio.
There is no alarm that goes off when this happens. No single day where a position crosses from “comfortable” to “concentrated.” It creeps. And because it creeps under the cover of good news — rising earnings, a climbing share price, the quiet satisfaction of having picked well — it rarely gets questioned with the same rigour a losing position would.
This is worth sitting with, because the instinct most investors reach for here is either too simple or too anxious. The too-simple instinct says: sell some, always, once a position crosses some round number like 20% or 30%. The too-anxious instinct says: never sell a winner, because selling feels like betting against yourself. Neither instinct is actually a decision. Both are shortcuts for avoiding one.
A more useful starting point is a question, not a rule: do you still understand this business as well as you did when you bought it? Concentration is not dangerous in the abstract. It is dangerous in proportion to how well you actually know what you own. An investor who built and ran their own company for twenty years, and who has spent that long calibrating their judgement of management, competitive position and capital allocation, can reasonably carry a larger position in a business they understand deeply than an investor who bought on a tip and has never read past the headline numbers.
That distinction matters more than any percentage. The comfortable size of a position is not a fixed number handed down from a textbook — it is a function of conviction, built on genuine understanding, tested by time. Two investors can look at the same 30% weighting in the same stock and reach entirely different, equally reasonable conclusions, because their underlying knowledge of the business is not the same.
Where this becomes genuinely practical is in how often the question gets asked. It does not need to be asked daily, or even monthly. A quarterly rhythm — deliberately, calmly, without the pressure of a looming decision — tends to be enough for most long-term portfolios. And here is the part that surprises newer investors: reviewing a position on schedule does not mean changing it on schedule. The healthiest outcome of most quarterly reviews is the decision to do nothing at all, because nothing about the business has actually changed, only its price.
That last distinction — between the business and its price — is where a great deal of unforced error lives. A share price falling does not automatically mean a business is broken, any more than a share price climbing automatically means a business has become a better one. Volatility, in either direction, is simply the market’s mood on a given day. It is not a verdict on the underlying company. Treating a period of volatility as an opportunity to look more closely — rather than a signal to react quickly — is the difference between a patient investor and a nervous one.
This is also why timing rarely rewards the effort put into it. Trying to sell at the exact top, or buy at the exact bottom, asks you to predict something genuinely unpredictable: the mood of millions of other people on a specific day. What can be assessed, with real discipline, is value — whether the price on offer today is a reasonable one for the business you believe you are buying, based on its fundamentals rather than its recent momentum. A company that looked expensive twelve months ago and looks fairly priced today has not become a worse business in the interim. It has simply become available on better terms, and a patient investor who missed it the first time often gets another chance within twelve to eighteen months, should the market’s mood swing again.
None of this removes the discomfort of a genuinely large position. It simply reframes the decision. The question is not “is this stock too big?” in isolation — it is “do I know this business well enough to be comfortable owning this much of it, and would I buy this much of it again today, at today’s price, if I were starting from scratch?” If the honest answer is no, trimming is not a loss of conviction. It is conviction, correctly applied.
The investors who tend to sleep best are not the ones who avoid concentration altogether, nor the ones who let a single position run unchecked out of loyalty to a good decision made years ago. They are the ones who keep asking the question — patiently, on a schedule, without needing every answer to be a change.
